Peripheral Arterial Disease Trial, Recruiting NCT07334834 Sponsor: Colorado Prevention Center Condition: Peripheral Arterial Disease
Back to Peripheral Arterial Disease

Peripheral Arterial Disease Trial, Recruiting

NCT07334834
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have agreed to take part and signed a consent form
  • You are 18 years of age or older
  • You have been diagnosed with atherosclerotic vascular disease (a condition where arteries are narrowed or blocked by fatty deposits), which may include: a history of heart artery disease (such as a prior heart attack, a procedure to open blocked heart arteries, or scan results showing artery disease); leg or foot artery disease (such as a prior procedure to open blocked leg arteries, an amputation, or test results showing poor blood flow to the legs); neck artery disease (such as a prior procedure on the neck arteries or scan results showing narrowing); or artery disease affecting other areas of the body such as the aorta, gut, or kidney arteries
  • Your LDL cholesterol level (often called "bad cholesterol") is above 70 mg/dL

Who may not be able to join:

  • The doctor running the trial believes, for any reason, that taking part could be harmful to you or that you would be unlikely to be able to follow the study requirements for its full duration — for example, if you have a terminal diagnosis or advanced cancer
  • You are currently having your cholesterol-lowering medication actively adjusted or changed
  • You have had a heart attack or a procedure to open blocked arteries within the last 30 days

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 14 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Marc Bonaca, MD, Colorado Prevention Center

Phone: (303) 860-9900

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Colorado Prevention Center
Registry
ClinicalTrials.gov
Start date
10 December 2025
Est. completion
1 May 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

The between group difference in LDL-C percent change

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov